TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Improvement in caregiver knowledge of fever
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medical necessity for subsequent febrile episodes
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of Carraguard
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: WeeFIM ratings
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean number of issues discussed per encounter
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: mean management composite score
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: mean 1L‐1beta level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Numbers of Bifidobacteriae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average time taken for IMF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall oral hygiene
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Needle stick injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of canal wall penetrated by sealer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum depth of sealer penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily sleep latency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: change in height SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in infantile colic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of (R)-p-HPPH at 36 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recovery of (S)-p-HPPH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Disability Rating Index (DRI) score at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conformity index (CI) of PTV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of Motion (ROM) at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gastro-duodenal endoscopy findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Discomfort during augmentation procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Surgical time required to place implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patient preference for Cosci technique
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: anatomic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vaginal bulge symptom failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: defecatory symptom failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insufficient variceal thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patent vessels detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oesophageal fibrosis observation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects achieving HbA1c levels <7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety and tolerability of the vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: NCEP LDL‐C goal attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage LDL‐C change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cumulative visual field progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: allergen sensitization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: systemic adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Recession reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BCVA improvement of 10 letters or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central retinal thickness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluorescein leakage improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial concentration of free tryptophan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral uptake of tryptophan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach a PaO2/FIO2 ratio of >300 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Joint awareness measured by FJS-12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral bioavailability of bilastine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent stroke/transient ischemic attack
Endpoint domain: Mortality/survival
Primary endpoint: Functional outcome (Barthel Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of t(2;5) translocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: food consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in measures of wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Best-corrected visual acuity after retinal detachment repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refractive change after retinal detachment repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived substantial pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical judgment and clinical reasoning skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alkaline phosphatase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Levels of TBil, DBil, TBA, ALP, ALT, AST, and γ‐GT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stool pattern stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with monitor usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day adverse outcome rate
Endpoint domain: Adverse events/effects
Primary endpoint: BUT scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular fatigue improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in severe dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plateau airway pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Murray lung injury score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interindividual variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic consumption (number of IM diclofenac injections in 24 hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall 24-hour pain VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of major coronary events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nicotine uptake (Cmax and AUC0‐360)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective measurements (product liking, intent to use product again, liking of positive product effects)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urge to smoke responses
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: NRS scores after expected vs unexpected pain stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS symptom severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative tramadol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure and mechanical pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival rate at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants entering community-based treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants testing positive for opioids at 1-month post-release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seattle Angina Questionnaire measures of anginal stability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Seattle Angina Questionnaire measures of anginal frequency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Success rates at 4, 8, and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression from CIN 2 to CIN 3
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of gastric distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Degree of change in gastric distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Specificity of serological diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of serological diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: overall function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: basic lower extremity function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: advanced lower extremity function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: asymmetric LEP deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: self-reported ability to walk outdoors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postanesthetic driving skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood donation rates for HBV biospecimen research
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Participant knowledge about biospecimen research
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Poor outcome (extended Glasgow Outcome Scale score ≤ 4)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SF-36 Mental Component Summary score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: haemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum percentage fall in forced expiratory volume in one second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: daytime symptoms of insomnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impaired working memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of target vessel failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of binary angiographic restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Use of HRT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Psychiatric symptoms stability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global functioning stability
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: DBS-related surgery frequency decrease
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: UV hand photographs values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sunnybrook score at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of enamel acid erosion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P(g-a) CO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of compensated covert shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to attain satisfactory goal of shock resuscitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of pediatric gastric tube insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: waist/height rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean power increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening Renal Function (WRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Absolute change in creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Neutrophil Gelatinase Associated Lipocalin (NGAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Specimen volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective ease of the procedures (cosmetic outcomes and postoperative pain)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: False negative detection of H. pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta (13)CO(2)/(12)CO(2) excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Second stage labor length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal descent rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relief of all symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Harris Hip Score (mHHS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip Outcome Score‐Activities of Daily Living (HOS‐ADL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip Outcome Score‐Sports‐Specific Subscale (HOS‐SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy rate of sleep stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: target lesion revascularisation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in WOMAC pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life improvements (HUI3 overall health utility score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Histological type of regenerated epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Concentrations >719 fmol/punch of TFV-DP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Vancouver Scar Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin closure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduction in pituitary tumor volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: necrotic core volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Eradication rates of pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term success rate of desensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who relapsed
Endpoint domain: Mortality/survival
Primary endpoint: RmS after 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RmA-RmP after 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycemic Index (GI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of disappearance of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: passage of stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total glucose uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effective pain medication management
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of passes to obtain sciatic nerve twitch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline VL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motivation to be physically active
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Distance biked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: down-regulation of GR mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cytokines response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cesarean delivery for dystocia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of duodenal ulceration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total ghrelin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total GLP-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Peak PBC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in SF-36 Physical Component Summary (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvements in SF-36 Mental Component Summary (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Median OS times
Endpoint domain: Mortality/survival
Primary endpoint: Myelosuppression severity and frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Detection rate of high-risk SSPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall success probability for intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regularity of menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ferriman score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of peritonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of ESI
Endpoint domain: Adverse events/effects
Primary endpoint: 30-day occurrence of death, myocardial infarction (MI), or target vessel revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Morning peak expiratory flow increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Asthma stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in depression severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to antidepressant medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean uterine blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial glucose (PPG) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: annualized loss of eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: HbA1c slopes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: on-drug headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alanine aminotransferase elevations
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid misuse risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PedsQL emotional functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental PODCI treatment expectations scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appraisal of competence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Successful drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EORTC global health status at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MRCP sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes